Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer
The Prostate2009Vol. 69(7), pp. 787–798
Citations Over TimeTop 10% of 2009 papers
Ganesh S. Palapattu, Chengyu Wu, Christopher Silvers, Heather B. Martin, Karin Williams, Linda Salamone, Timothy Bushnell, Li‐Shan Huang, Qi Yang, Jiaoti Huang
Abstract
Selective expression of the stem cell-associated marker CD44 in NE tumor cells of PC, in combination with their other known features, further supports the significance of such cells in therapy resistance and tumor recurrence.
Related Papers
- → Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck(2008)167 cited
- → CD44+CD133+population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma(2010)81 cited
- → Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells(2019)16 cited
- → The CD44std and CD44v9 subpopulations in non-tumorigenic invasive SNU-423 cells present different features of cancer stem cells(2023)3 cited
- → Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies(2014)7 cited